ATE400290T1 - Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetain - Google Patents

Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetain

Info

Publication number
ATE400290T1
ATE400290T1 AT04809251T AT04809251T ATE400290T1 AT E400290 T1 ATE400290 T1 AT E400290T1 AT 04809251 T AT04809251 T AT 04809251T AT 04809251 T AT04809251 T AT 04809251T AT E400290 T1 ATE400290 T1 AT E400290T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
detergent
sulfobetain
composition containing
ndsb
Prior art date
Application number
AT04809251T
Other languages
English (en)
Inventor
Viktor Menart
Porekar Vladka Gaberc
Barbara Podobnik
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE400290T1 publication Critical patent/ATE400290T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04809251T 2003-12-23 2004-12-22 Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetain ATE400290T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200300318A SI21639A (sl) 2003-12-23 2003-12-23 Farmacevtski pripravek, ki vsebuje nemicelarne sulfobetaine

Publications (1)

Publication Number Publication Date
ATE400290T1 true ATE400290T1 (de) 2008-07-15

Family

ID=34709498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04809251T ATE400290T1 (de) 2003-12-23 2004-12-22 Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetain

Country Status (14)

Country Link
US (1) US7906109B2 (de)
EP (1) EP1729794B1 (de)
JP (1) JP4971798B2 (de)
CN (1) CN1897967B (de)
AT (1) ATE400290T1 (de)
AU (1) AU2004305421B2 (de)
BR (1) BRPI0417265A (de)
CA (1) CA2545632C (de)
DE (1) DE602004014991D1 (de)
ES (1) ES2308292T3 (de)
RU (1) RU2380112C2 (de)
SI (2) SI21639A (de)
WO (1) WO2005060989A1 (de)
ZA (1) ZA200604657B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101116670B (zh) * 2006-08-01 2010-11-10 广州和竺生物科技有限公司 可提供活性甲基或参与甲基转移的化合物作为制备治疗病毒性疾病的药的应用
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にgdf−5を含むタンパク質製剤
BRPI0911048A2 (pt) 2008-04-14 2015-12-29 Atrm Llc formulações líquidas tamponadas de gdf-5
RU2435589C2 (ru) * 2009-06-02 2011-12-10 Федеральное государственное учреждение "Государственный научный центр дерматовенерологии и косметологии" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "ГНЦДК Минздравсоцразвития России) Состав консервирующей добавки к контрольным материалам, используемым при серодиагностике сифилиса
UY34105A (es) 2011-06-03 2012-07-31 Lg Life Sciences Ltd Formulación líquida estable de etanercept
CN107233569B (zh) 2011-10-25 2021-08-31 普罗西纳生物科学有限公司 抗体制剂和方法
GB201315321D0 (en) 2013-08-28 2013-10-09 Koninklijke Nederlandse Akademie Van Wetenschappen Transduction Buffer
WO2015079977A1 (ja) * 2013-11-26 2015-06-04 シャープ株式会社 抗体分離方法、抗体評価方法、医薬の評価方法、及び、抗体の2次元電気泳動用キット
GB201521101D0 (en) 2015-11-30 2016-01-13 Koninklijke Nederlandse Akademie Van Wetenschappen Transduction buffer
CN112933039A (zh) * 2019-12-11 2021-06-11 深圳赛保尔生物药业有限公司 一种重组人促红细胞生成素液体制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3364292D1 (en) * 1982-02-03 1986-08-07 Procter & Gamble Oxygen-bleach-containing liquid detergent compositions
DE3880923T3 (de) * 1987-02-23 1997-12-18 Shiseido Co Ltd Perkutaner absorptionspromotor und dermatologische zusammensetzung für externe anwendung.
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
US5550416A (en) * 1995-02-09 1996-08-27 Fanchang; We C. Control mechanism of revolving speed of an electric tool
DE19549232C2 (de) * 1995-12-20 1998-05-20 Boehringer Mannheim Gmbh Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern
EP0904345A4 (de) * 1996-01-12 1999-07-07 Procter & Gamble Desinfizierende zusammensetzungen und verfahren zum desinfizieren von oberflächen
US6103683A (en) 1996-01-12 2000-08-15 The Procter & Gamble Co. Disinfecting compositions and processes for disinfecting surfaces
CZ218798A3 (cs) * 1996-02-23 1999-07-14 The Procter & Gamble Company Dezinfekční prostředky
SE9801288D0 (sv) 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
SI21273A (sl) * 2002-07-31 2004-02-29 LEK farmacevtska dru�ba d.d. Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina

Also Published As

Publication number Publication date
AU2004305421B2 (en) 2010-07-08
ES2308292T3 (es) 2008-12-01
RU2006126784A (ru) 2008-01-27
SI1729794T1 (sl) 2008-12-31
CN1897967A (zh) 2007-01-17
WO2005060989A1 (en) 2005-07-07
JP4971798B2 (ja) 2012-07-11
EP1729794A1 (de) 2006-12-13
JP2007516281A (ja) 2007-06-21
BRPI0417265A (pt) 2007-03-06
ZA200604657B (en) 2007-10-31
DE602004014991D1 (de) 2008-08-21
AU2004305421A1 (en) 2005-07-07
CN1897967B (zh) 2010-09-08
EP1729794B1 (de) 2008-07-09
US20070184019A1 (en) 2007-08-09
CA2545632A1 (en) 2005-07-07
RU2380112C2 (ru) 2010-01-27
SI21639A (sl) 2005-06-30
US7906109B2 (en) 2011-03-15
CA2545632C (en) 2014-10-14

Similar Documents

Publication Publication Date Title
ATE407663T1 (de) Azithromycin enthaltende pharmazeutische zusammensetzungen mit verringerten nebenwirkungen
CY1108547T1 (el) Αναλογα σωματοστατινης
EP1506786A4 (de) Medizinische, ghrelin enthaltende zusammensetzungen
EP1603593A4 (de) Pharmazeutische zusammensetzung
ATE480518T1 (de) Chemische verbindung
EP1425019A4 (de) Pharmazeutische zusammensetzung
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1596870T4 (da) Højdosis-ibandronatformulering
ATE400290T1 (de) Pharmazeutische zusammensetzung mit einem nicht- detergens sulfobetain
DE60333825D1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
DE60211183D1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
BRPI0417950A (pt) composições farmacêuticas
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
EP1611147A4 (de) 6"-amino-6"-deoxygalactosylceramide
BRPI0408446A (pt) tablete de limpeza
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
NO20063293L (no) Farmasoytiske forbindelser
DE602004027808D1 (de) Tablette enthaltend fluvastatin und calciumcarmellose
DE602004022420D1 (de) Pharmazeutische zusammensetzungen, die cyclische somatostatinanaloga enthalten
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE602004016751D1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung
DE60216332D1 (de) Antioxydationsmittel aus natürlicher quelle
DE10107261B4 (de) Pharmazeutische Zusammensetzung
NO20044164L (no) Farmasoytiske sammensetninger
ITMI20030705A1 (it) Composizione farmaceutica contenente n-acetil-l-cisteina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1729794

Country of ref document: EP